Competence course on psychedelics
The course's target audience and theme:
This course is a basic course aimed at authorized healthcare personnel who work at various levels within public and private healthcare. This includes doctors, psychologists, nurses, social workers, psychomotor physiotherapists etc. The course can be seen as a basic course that provides an overview of historical and current research on psychedelic substances.
In this course there will be a focus on classic psychedelic substances (LSD, psilocybin, mescaline and DMT). It will also be taught briefly about nearby hallucinogens such as MDMA and Ketamine. There will be an emphasis on updating knowledge related to potential treatment effects, the psychedelic treatment model, the substances' risk factors and harmful effects of recreational use.
In addition, there will be a focus on how a therapist can use this knowledge in meetings with the user group in the form of good harm reduction conversations with an emphasis on equality, autonomy and knowledge.
​
In 2023, we have held 5 one-day courses for over 60 healthcare personnel with good feedback:
Learning outcomes:
-
Get up-to-date knowledge about the evidence for the use of psychedelic substances in the treatment of mental disorders.
-
A basic introduction to the various types of historical and current psychotherapy models (psychedelic vs. psycholytic).
-
Knowledge of the actual risk factors when using psychedelic substances
-
Basic understanding of how a therapist can create a good therapeutic dialogue with patients who use psychedelic substances.
Course instructors:
​
Christopher Andersen.
Psychologist and PhD scholar at OUS. Previous research experience from London Imperial College, Center for Psychedelic Research. Worked with quality assurance of therapists in the clinical studies where MDMA-assisted psychotherapy studies for MAPS, and with Ketamine-assisted psychotherapy from 2021-2023. Co-founder of Norwegian Psychedelic Science and initiator of Psycholysis.
​
Bjørn Holmøy.
Psychologist with research experience from MindBodyLab, UiO. Works with quality assurance of the therapists who provide MDMA-assisted therapy for MAPS. Currently working mainly as a psychologist at the Cancer Department of Aker Hospital and in the evenings at Psykolyse.
Time and place:
27/01/2024 7 available places
Saturday 27 January 2024 at 09.00-15.00. The course is held at our premises, Bogstadveien 11, 0355 Oslo.
​
